Co-Authors
This is a "connection" page, showing publications co-authored by Oliver Keppler and Jindrich Cinatl.
Connection Strength
0.229
-
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nat Med. 2017 06 06; 23(6):788.
Score: 0.180
-
The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc Natl Acad Sci U S A. 2018 10 23; 115(43):E10022-E10031.
Score: 0.049